Literature DB >> 11255487

Treatment of Frey syndrome with botulinum toxin type F.

V Tugnoli, R Marchese Ragona, R Eleopra, D De Grandis, C Montecucco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11255487

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN： 0886-4470


× No keyword cloud information.
  6 in total

Review 1.  Treatment of complications of parotid gland surgery.

Authors:  R Marchese-Ragona; C De Filippis; G Marioni; A Staffieri
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

Review 2.  The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome.

Authors:  D A Glaser
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 3.  Botulinum toxin therapy: functional silencing of salivary disorders.

Authors:  A Lovato; D A Restivo; G Ottaviano; G Marioni; R Marchese-Ragona
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-04       Impact factor: 2.124

4.  Quality of life following surgical treatment of benign parotid disease.

Authors:  Behçet Gunsoy; Erkan Vuralkan; Nevreste Didem Sonbay; Gokce Simsek; Sibel Alicura Tokgoz; Istemihan Akin
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-10-30

5.  [First use of botulinum toxin type B in ENT patients with secondary therapy failure of botulinum toxin type A].

Authors:  O Guntinas-Lichius
Journal:  HNO       Date:  2003-06-17       Impact factor: 1.284

6.  Management of parotid fistula and Frey's syndrome with Botulinum neurotoxin type A.

Authors:  Ripon Chowdhury; Dev Roy; Abhimanyu Roy
Journal:  Natl J Maxillofac Surg       Date:  2021-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.